WELCOME TO HARBOR MEDTECH, INC.
Delivering on the Promise of Regenerative Medicine
Harbor MedTech, Inc. is a fully integrated, commercial-stage regenerative medicine company focused on advanced orthopedic soft tissue repair solutions using our patented BriDGE® technology.
Our BriDGE® Technology transforms readily available, intact Type-1 collagen into a bio-friendly, stabilized collagen matrix which acts as a trigger to activate the patient’s own healing cascade.
Pre-clinical and clinical experience has demonstrated that our BriDGE-processed collagen matrix, when applied to chronic skin wounds or internal soft tissue injuries, acts to:
Accelerate wound healing;
Activate & support tissue regeneration;
Limit the formation of scar tissue and
Limit the formation of infectious biofilm.
Harbor MedTech currently has two FDA-cleared & CE marked products, & a broad pipeline that leverages our patented BriDGE® Collagen Processing Technology.
Our product pipeline is addressing:
Orthobiologic Soft Tissue (Sports Medicine) injuries;
General Surgical Repair of Hernia & Breast Reconstruction;
Difficult to Heal Chronic Skin Wounds.